SCHEMBL7464801

SCHEMBL7464801

O=C(Nc1nccc2ccccc12)c1c[nH]cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.47
BRD4 O60885 1/20 0.46
CREBBP Q92793 1/20 0.46
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42
CNR2 P34972 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ADORA3 P0DMS8 4/20 0.41
RAB9A P51151 2/20 0.40
MAP3K7 O43318 1/20 0.38
MAP3K6 O95382 1/20 0.38
MAP3K5 Q99683 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
NPC1 O15118 1/20 0.37
POLB P06746 1/20 0.37
KMT2A Q03164 1/20 0.37
CDK2 P24941 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13727980 0.78 ADORA3 (0.52) FDPSBRD4CREBBPDRD2DRD4
SCHEMBL5874038 0.77 ADORA3 (0.62) FDPSCNR2ADORA3RAB9ANPC1
SCHEMBL3800642 0.77 SMN1; SMN2 (0.69) FDPSSMN1; SMN2ADORA3RAB9AKDM4E
SCHEMBL4879083 0.76 FDPS (0.47) FDPSBRD4CREBBPDRD2DRD4
SCHEMBL29825764 0.75 FDPS (0.54) FDPSBRD4CREBBPDRD2DRD4
SCHEMBL7599559 0.75 FDPS (0.54) FDPSBRD4CREBBPDRD2DRD4
SCHEMBL10051128 0.73 FDPS (0.53) FDPSBRD4CREBBPDRD2DRD4
SCHEMBL4411955 0.73 FDPS (0.53) FDPSBRD4CREBBPDRD2DRD4
SCHEMBL2361181 0.73 KDM4E (0.56) FDPSBRD4CREBBPDRD2DRD4
SCHEMBL7937683 0.73 FDPS (0.49) FDPSBRD4CREBBPDRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4843077-A Isoquinoline derivatives having renal vasodilating properties and/or cardiotonic properties and/or phosphodiesterase inhibiting properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-06-27 US disclosed